ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.

Ryuichi Kanai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.